News from the FDA/CDC

E-cig use reverses progress in reducing tobacco use in teens


 

FROM CDC VITAL SIGNS REPORT

A significant increase during 2017-2018 in e-cigarette use among U.S. youths has erased recent progress in reducing overall tobacco product use in this age group, a study from the Centers for Disease Control and Prevention has found.

CDC smoking graphic Courtesy CDC
Nearly 5 million middle school and high school students in the United States, approximately 27% of high school students and 7% of middle school students, used tobacco products, including e-cigarettes, in 2018, according to study findings.

E-cigarettes are driving the trend. About 4 million high school students in the United States reported using any tobacco product in the last 30 days, and 3 million of them reported using e-cigarettes, according to a Vital Signs document published by the CDC on Feb. 11 in its Morbidity and Mortality Weekly Report.*

In addition, many high school students who use e-cigarettes use them often; 28% reported using the products at least 20 times in the past 28 days, up from 20% in 2017.

“Any use of any tobacco product is unsafe for teens,” Anne Schuchat, MD, principal deputy director of the CDC, said in a teleconference to present the findings. Nicotine is highly addictive and can harm brain development in youth, including capacity for learning, memory, and attention, she said.

The rise in e-cigarette use corresponds with the rise in marketing and availability of e-cigarette devices such as JUUL, which dispense nicotine via liquid refill pods available in flavors including strawberry and cotton candy, said Brian King, MPH, PhD, deputy director for research translation at the CDC’s Office on Smoking and Health.

“The advertising will lead a horse to water, the flavors will make them drink, and the nicotine will keep them coming back for more,” said Dr. King.

Pages

Recommended Reading

Pediatricians get more guidance to be proactive on youth e-cig use
MDedge Pediatrics
Flu activity increases after 2 weeks of declines
MDedge Pediatrics
Mild OSA spontaneously resolves in about one-third of young children
MDedge Pediatrics
Flu activity ticks up for second week in a row
MDedge Pediatrics
FDA approves generic Advair Diskus
MDedge Pediatrics
No increase in severe community-acquired pneumonia after PCV13
MDedge Pediatrics
Asthma, obesity, and the risk for severe sleep apnea in children
MDedge Pediatrics
Nonsurgical OSA treatment ineffective in children with Down syndrome
MDedge Pediatrics
Flu activity hits seasonal high
MDedge Pediatrics
ALA report: Federal and state actions to limit tobacco use fall short
MDedge Pediatrics